Executive Committee

The Executive Committee is ECNP’s executive organ. It is charged with setting the organisation’s strategic agenda, planning its activities, representing it publicly and managing its funds and assets, subject to the final oversight of the General Assembly.

Officers

Councillors

Advisers and ex-officio members

Composition

The Executive Committee consists of up to twelve voting members: six officers – the president, vice-president, president-elect, past-president, secretary and treasurer – and up to six councillors. In addition, selected experts and advisers, and ex-officio members can be invited to participate to represent special areas of expertise. Voting members sit for three-year terms, and can be re-elected a maximum of three times.

2022-2025 Executive Committee
Martien Kas, The Netherlands
President
Alexander Schubert, The Netherlands
Executive Director
Elisabeth Binder, Germany
Vice-president
Paolo Brambilla, Italy
Gitte Knudsen, Denmark
Past-president
David Baldwin, United Kingdom
Andreas Reif, Germany
President-elect
Gerry Dawson, United Kingdom
Brenda Penninx, The Netherlands
Treasurer
Iria Grande, Spain
Suzanne Dickson, Sweden
Secretary
Iiris Hovatta, Finland
John Cryan, Ireland
Chair Scientific Programme Committee
Marin Jukic, Serbia
Eduard Vieta, Spain
Editor-in-Chief European Neuropsychopharmacology
Marion Leboyer, France
2019-2022 Executive Committee
Gitte Knudsen, Denmark
President
David Baldwin, United Kingdom
Celso Arango, Spain
Past-president
Elisabeth Binder, Germany
Martien Kas, The Netherlands
President-elect
Gerry Dawson, United Kingdom
Catherine Harmer, United Kingdom
Treasurer
Damiaan Denys, The Netherlands
Suzanne Dickson, Sweden
Secretary
Marion Leboyer, France
Andreas Reif, Germany
Chair Scientific Programme Committee
Brenda Penninx, The Netherlands
Eduard Vieta, Spain
Editor-in-Chief European Neuropsychopharmacology
Andreas Reif, Germany
Alexander Schubert, The Netherlands
Executive Director
Gil Zalsman, Israel